Latest Sustainable Growth News

Auric Mining has successfully completed its first gold pour from the Munda Starter Pit ahead of schedule, setting the stage for imminent gold sales and cash flow. This milestone marks a significant step in Auric’s growth trajectory as it prepares for expanded production in 2026.

Ora Banda Mining Ltd reported a record September quarter with a 39% surge in gold production and a 37% rise in gold sales, underpinned by strong operational performance and exploration success.

Weebit Nano has reported a fourfold revenue increase in FY25, driven by a landmark licensing agreement with semiconductor giant onsemi and key automotive-grade qualification for its ReRAM technology.

IDT Australia announces a strategic realignment focusing on profitability and operational efficiency, reporting strong revenue growth from its three core verticals and securing $3.4 million in new contracts for FY26.

Wellnex Life Limited announces the resignation of CEO Zack Bozinovski, who will remain with the company until April 2026, while a $2.3 million loan repayment schedule is negotiated.

Tasman Resources has raised $2 million through a two-tranche placement to fund a promising drilling campaign at Parkinson Dam and broaden its project portfolio, alongside appointing a new director to steer its strategic ambitions.

BPH Global Ltd reports a steady increase in Indonesian seaweed sales alongside securing a crucial export licence, setting the stage for international market entry.

Central Petroleum has secured a new 1.3 petajoule gas supply agreement with McArthur River Mining, enhancing cash flow certainty through fixed pricing and take-or-pay terms.

Judo Capital Holdings Limited reported strong FY25 results with significant lending growth and profit increases, while expanding its SME banking footprint and advancing technology. The bank sets confident FY26 guidance amid strategic board changes.

Genetic Signatures Ltd reports a robust start to FY2026 with a 20% quarterly sales increase, driven by new US contracts and strong growth in EMEA and Australia. The company also bolsters its leadership with a new CTO appointment.

Mesoblast Limited reports a 69% jump in net revenues from its pioneering cell therapy Ryoncil in Q1 FY2026, propelled by expanded physician adoption and new reimbursement pathways. The company also secures convertible note funding and plans pivotal adult trials.

Raiz Invest has hit a record $2 billion in funds under management, driven by strong customer growth and innovative product launches. The fintech’s latest quarter also saw strategic partnerships expand its market reach.